<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kersten E</submitter><funding>European Research Council</funding><funding>European Commission</funding><pagination>569-574</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6282796</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>94(6)</volume><pubmed_abstract>It can be clinically challenging to distinguish dry age-related macular degeneration (AMD) from AMD-mimicking dystrophies, and sometimes misdiagnosis occurs. With upcoming therapies for dry AMD it is important to exclude patients with a different retinal disease from clinical trials. In this study we evaluated the occurrence of AMD-mimicking dystrophies in an AMD cohort. Whole-exome sequencing (WES) was performed in 218 patients with intermediate AMD or geographic atrophy secondary to AMD and 133 control individuals. WES data was analyzed for rare variants in 19 genes associated with autosomal dominant and recessive macular dystrophies mimicking AMD. In three (1.4%) of 218 cases we identified a pathogenic heterozygous variant (PRPH2 c.424C > T; p.R142W) causal for autosomal dominant centra</pubmed_abstract><journal>Clinical genetics</journal><pubmed_title>Genetic screening for macular dystrophies in patients clinically diagnosed with dry age-related macular degeneration.</pubmed_title><pmcid>PMC6282796</pmcid><funding_grant_id>310644 (MACULA)</funding_grant_id><funding_grant_id>634479 (EYE‐RISK)</funding_grant_id><funding_grant_id>310644</funding_grant_id><pubmed_authors>Fauser S</pubmed_authors><pubmed_authors>de Jong EK</pubmed_authors><pubmed_authors>Hoyng CB</pubmed_authors><pubmed_authors>den Hollander AI</pubmed_authors><pubmed_authors>Corominas J</pubmed_authors><pubmed_authors>Pauper M</pubmed_authors><pubmed_authors>Bakker B</pubmed_authors><pubmed_authors>Altay L</pubmed_authors><pubmed_authors>Kersten E</pubmed_authors><pubmed_authors>Geerlings MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic screening for macular dystrophies in patients clinically diagnosed with dry age-related macular degeneration.</name><description>It can be clinically challenging to distinguish dry age-related macular degeneration (AMD) from AMD-mimicking dystrophies, and sometimes misdiagnosis occurs. With upcoming therapies for dry AMD it is important to exclude patients with a different retinal disease from clinical trials. In this study we evaluated the occurrence of AMD-mimicking dystrophies in an AMD cohort. Whole-exome sequencing (WES) was performed in 218 patients with intermediate AMD or geographic atrophy secondary to AMD and 133 control individuals. WES data was analyzed for rare variants in 19 genes associated with autosomal dominant and recessive macular dystrophies mimicking AMD. In three (1.4%) of 218 cases we identified a pathogenic heterozygous variant (PRPH2 c.424C > T; p.R142W) causal for autosomal dominant centra</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Dec</publication><modification>2025-04-04T12:41:39.882Z</modification><creation>2019-03-27T00:11:16Z</creation></dates><accession>S-EPMC6282796</accession><cross_references><pubmed>30215852</pubmed><doi>10.1111/cge.13447</doi></cross_references></HashMap>